Company: HCTI
Filing Date: 2025-04-01
Form Type: S-1
Source: 0001213900-25-027277
Chunk: 41

Company: Healthcare Triangle, Inc.
Filing Date: 2025-04-01
Form: S-1
Chunk 41
---
 Consent of Sichenzia Ross Ference Carmel LLP (included in Exhibit 5.1)                                                                                                                                                                                                             |
| 97.1  |     | Healthcare Triangle, Inc. Clawback Policy, effective November 29, 2023 (incorporated by reference to Exhibit 10.1 to the Company’s current report on Form 8-K, filed with the SEC on November 29, 2023)                                                                            |
| 107*  |     | Exhibit Filing Fees                                                                                                                                                                                                                                                                |

| * | Filed herewith |

(b) Financial Statement Schedules.

All financial statement schedules are omitted
because the information called for is not required or is shown either in the financial statements or in the notes thereto.

<div align='center'>II-6</div>

Item 17. Undertakings

The undersigned registrant hereby undertakes:

(1) To file, during any period in which offers
or sales are being made, a post-effective amendment to this registration statement:

(i) To include any prospectus required
by section 10(a)(3) of the Securities Act of 1933, as amended (the “Securities Act”);

(ii) To reflect in the prospectus any
facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which,
individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding
the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed
that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the
form of prospectus filed with the Securities and Exchange Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume
and price represent no more than a 20 percent change in the maximum aggregate offering price set forth in the “Calculation of Registration
Fee” table in the effective registration statement; and

(iii) To include any material information
with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information
in the registration statement;

Provided, however, that:

Paragraphs (1)(i), (1)(ii) and (1)(iii)
above do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports
filed with or furnished to the Securities and